Lexaria Bioscience (LEXX) Asset Writedowns and Impairment (2010 - 2025)
Lexaria Bioscience's (LEXX) quarterly Asset Writedowns and Impairment came in at -$33540.0 in Q3 2025, down 348.44% quarter-over-quarter from $13500.0 in Q3 2021.
Lexaria Bioscience (LEXX) Asset Writedowns and Impairment (2010 - 2025) Analysis & Trends
Lexaria Bioscience has disclosed Asset Writedowns and Impairment across 8 years of filings, most recently posting -$33540.0 for Q3 2025.
- Asset Writedowns and Impairment for Q3 2025 came in at -$33540.0, changed N/A year-over-year; the trailing twelve-month figure through Aug 2025 was -$33540.0 (changed N/A YoY), and the FY2024 annual result was $57836.0, changed N/A from the prior year.
- Asset Writedowns and Impairment came in at -$33540.0 for Q3 2025 at Lexaria Bioscience, down from $13500.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $13500.0 in Q3 2021 to a low of -$33540.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Lexaria Bioscience | 7.63 Mn | 2.11 Mn | 20,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Aug 31, 2025 | -33,540.00 |
| Aug 31, 2025 | -33,540.00 |
| Aug 31, 2021 | 13,500.00 |
| Aug 31, 2021 | 13,500.00 |
| Feb 28, 2021 | 717.00 |
| Feb 28, 2021 | 717.00 |
| Nov 30, 2020 | 1,765.00 |
| Nov 30, 2020 | 1,765.00 |
| Aug 31, 2020 | 41,760.00 |
| Aug 31, 2020 | 41,760.00 |
| May 31, 2020 | 8,240.00 |
| May 31, 2020 | 8,240.00 |
| Aug 31, 2018 | 357.00 |
| Aug 31, 2018 | 357.00 |
| May 31, 2018 | 3,625.00 |
| May 31, 2018 | 3,625.00 |
| Feb 28, 2018 | 5,438.00 |
| Feb 28, 2018 | 5,438.00 |
| Nov 30, 2017 | 3,546.00 |
| Nov 30, 2017 | 3,546.00 |